Chitosan osteoarthritis gene delivery

Author: veev

August undefined, 2024

WebJan 1, 2024 · Thermoresponsive DDS, chitosan-modified MoS 2 (molybdenum disulfide), was shown to release a small molecule drug, dexamethasone (Dex) ... is most commonly employed osteoarthritis therapeutic for gene delivery; currently there are two ongoing trials for intra-articular delivery using an AAV (NCT02790723) and an HDAV … WebJan 28, 2024 · Methods In this study, an injectable and self-healing hydrogel was synthesized by in situ crosslinking of N -carboxyethyl chitosan ( N -chitosan), adipic acid dihydrazide (ADH), and hyaluronic...

Chitosan in Biomedical Applications - 1st Edition - Elsevier

WebAug 31, 2024 · Chitosan-based carriers have been recently considered for transporting hydrophobic agents such as chemotherapeutic compounds, therapeutic peptides, and nucleic acids ( e.g. DNA and siRNA) [67], [68]. 5限時間

Chitosan for gene delivery: Methods for improvement and applications

WebJun 23, 2024 · Nanoparticle-based local gene transfer can alter the expression of the endogenous genes to prevent or slow the pathological progress of OA by introducing genes, such as DNA, mRNA, siRNA, and miRNA, into the target cells. WebFeb 15, 2024 · 1. Introduction. Osteoarthritis (OA) is a progressive and degenerative joint disease that causes articular cartilage damage, synovial inflammation, and subchondral bone remodeling [1].World Health Organization (WHO) estimates that 9.6% of men and 18.0% of women aged over 60 years have symptomatic OA [2].OA affects life quality of … WebJun 1, 2024 · Modifying chitosan with target ligands is a promising method for the targeted delivery of genes by delivery systems based on chitosan. Proteins, peptides, aptamers, carbohydrates, and small molecules are common ligands used to realize target delivery in gene vectors based on chitosan. 5限主義

Chondroitin sulfate modified chitosan nanoparticles as an …

Ectopic chondrogenesis of nude mouse induced by nano gene delivery ...

WebDec 17, 2024 · To construct a novel non-viral vector loaded with growth and differentiation factor-5 (GDF-5) plasmid using chitosan, hyaluronic acid, and chondroitin sulfate for osteoarthritis (OA) gene therapy. Methods Nano-microspheres (NMPs) were prepared by mixing chitosan, hyaluronic acid, and chondroitin sulfate. WebThingreila Muinao, ...Mintu Pal, in Polysaccharide Carriers for Drug Delivery, 2024. 15.4.2.9 Chondroitin sulfate. Chondroitin sulfate is a natural water soluble polymer comprising of repeating disaccharide units of d-glucuronic acid and N-acetylgalactosamine, sulfated at either 4- or 6-positions.While cross-linked chondroitin sulfates may show less hydrophilic … 5限可能WebSep 14, 2024 · Chitosan is a derivation from chitin. Its favorable biological properties including biocompatible, biodegradable, and non-toxicity, make chitosan as a promising drug delivery carrier. In addition, chitosan is a water-soluble polymer which makes the process of preparation easier and milder. 5限英語

"WebNov 28, 2011 · Gene therapy is a promising new treatment strategy for common joint-disorders such as osteoarthritis. The development of safe, effective, targeted non-viral … " - Chitosan osteoarthritis gene delivery

Chitosan osteoarthritis gene delivery

Chitosan - an overview ScienceDirect Topics

WebMar 3, 2006 · Next, chitosan–DNA nanoparticles containing IL-1Ra or IL-10 gene were injected directly into the knee joint cavities of osteoarthritis rabbits to clarify the in vivo … WebOsteoarthritis (OA) is a painful, degenerative and inflammatory disease that affects the entire synovial joints. Nowadays, no cure exists, and the pharmacological treatments …

Did you know?

WebFeb 23, 2024 · Keywords: Osteoarthritis, Gene therapy, Chitosan, Hyaluronic acid, Chondroitin sulfate, Growth and differentiation factor-5 (GDF-5) plasmid. 1. ... HA and CHS enabled the non-viral vector itself to have some therapeutic effects on OA, making it much more suitable for delivery of gene therapy treatments for OA. WebMar 3, 2006 · All these studies point to the versatility and promise of chitosan as a gene carrier, although only limited in vivo efficacy has been demonstrated. Due to the complex …

WebJan 2, 2014 · The development of safe and efficient gene carriers is the key to the clinical success of gene therapy. The present study was designed to develop and evaluate the chitosan-graft-polyethylenimine (CP)/DNA nanoparticles as novel non-viral gene vectors for gene therapy of osteoarthritis. WebConventional treatments for osteoarthritis (OA), including drug delivery and tissue engineering approaches, could not offer a high yield of cartilage repair due to the compact and exclusive structure of cartilage. Targeted and high-efficiency delivery of gene sequences is necessary to rebalance the lost homeostatic properties of the cartilage ...

WebIntroduction. Cartilage injury, a common clinical problem, can be caused by trauma, 1 osteoarthritis, 2 rheumatoid arthritis, 3 and exfoliative chondritis. 4 Articular cartilage is … WebIntroduction. Cartilage injury, a common clinical problem, can be caused by trauma, 1 osteoarthritis, 2 rheumatoid arthritis, 3 and exfoliative chondritis. 4 Articular cartilage is a non-vascular tissue, whose regeneration ability is extremely limited. 5,6 Most believe that the damage of mature articular cartilage is partial or superficial, and cartilage cannot …

WebChitosan–pDNA nanoparticle characteristics determine the transfection efficacy of gene delivery to human mesenchymal stem cells E Malakooty Poor, M Baghaban Eslaminejad, N Gheibi, F Bagheri, ... Artificial cells, nanomedicine, and biotechnology 42 (6), 376-384 , 2014

WebJan 28, 2024 · Chitosan is considered as an ideal material for hydrogels for its biocompatibility, progressive degradability, non-toxic, biological activity, anti-inflammatory … 5限行WebConclusions: These results suggested that HA/CS-CrmA nanoparticles could attenuate cartilage destruction and protect against early OA by inhibiting synovial inflammation via … 5限速牌WebApr 11, 2024 · 1.3.1.Advantageous properties of chitosan as a biomaterial. Chitosan has a structure similar to that of glycine aminoglycan, which is widely distributed in connective tissue, giving chitosan good biocompatibility (Malafaya et al., 2007).Chitosan-based biomaterials do not cause cytotoxicity or genotoxicity and promote cell proliferation and … 5院4系是指什么WebChitosan can act itself as a precursor or carrier for medical applications such as drug delivery, gene delivery, and wound healing. With the advancement in science … 5限想象WebJun 6, 2024 · Chitosan is a linear copolymer composed by glucosamine and N -acteyl glucosamine units, via β- (1, 4) linkages, namely 2-amino-2-deoxy-β-d-glucan (Fig. 2 a). Chitosan is the product of the deacetylation reaction of chitin (2-acetamido-2 … 5院501WebSep 24, 2024 · 2.1. Solubility. Chitosan is produced by deacetylation of chitin; in this process, some N-acetylglucosamine moieties are converted into glucosamine units.The presence of large amounts of protonated -NH 2 groups on the chitosan structure accounts for its solubility in acid aqueous media since its pKa value is approximately 6.5 [].When … 5院504所WebNov 15, 2024 · (1) Background: Collagen is the main component of the connective tissue, playing an important role in the histological architecture and function of living organisms. Targeted therapy and improved imaging diagnosis can be obtained through collagen-binding nanoparticles that concentrate in the extracellular matrix. (2) Methods: We performed a … 5院501所